single5MG
MGF
5MG Protocol
MGF 5MG
Injection Freq.
Inject once daily
Cycle Sched.
8–12 weeks; optional extension to 16 weeks
Reconstitution
3.0 mL BAC water
Supports satellite-cell activation and muscle repair signaling in preclinical studies
Bone-regeneration/osteoblast-activity signals in animal models
Neurogenesis/neuroprotection signals described in aging research
Localized, tissue-specific repair signaling concept rather than systemic growth-factor exposure
1
Reconstitution Requirements
- 3.0 mL BAC water
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–1 | 100 mcg (0.1 mg) | 6 |
| 2 | Weeks 2–2 | 150 mcg (0.15 mg) | 9 |
| 3 | Weeks 3–3 | 200 mcg (0.2 mg) | 12 |
| 4 | Weeks 4–4 | 250 mcg (0.25 mg) | 15 |
| 5 | Weeks 5–8 | 300 mcg (0.3 mg) | 18 |
Inject once daily
8–12 weeks; optional extension to 16 weeks
Mechano Growth Factor (MGF) is described as an IGF-1 splice variant (IGF-1Ec in humans) that is naturally produced in response to mechanical loading or tissue injury. Unlike systemic IGF-1, the protocol frames MGF as a more local, tissue-specific repair signal because of its unique C-terminal ‘E’ domain. In the ‘How This Works’ section, MGF is described as supporting satellite-cell (muscle stem cell) activation and myoblast proliferation—processes that can initiate repair and regeneration following muscle strain or training stress. The page also summarizes preclinical literature linking MGF-related signaling to osteoblast activity and bone-defect healing and to neurogenesis/neuroprotective signals in aging models. A practical note included is that MGF is short-lived; therefore, repeated dosing protocols are designed to provide recurring exposure rather than sustained levels. Overall, the mechanism is presented as transient, localized growth-factor signaling that helps coordinate repair and remodeling in injured or stressed tissues.
Mild injection-site reactions (redness/itching)
Limited human safety/efficacy data (no formal human clinical trials described)
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)